Spinal Cord Research Help
AboutCategoriesLatest ResearchContact
Subscribe
Spinal Cord Research Help

Making Spinal Cord Injury (SCI) Research Accessible to Everyone. Simplified summaries of the latest research, designed for patients, caregivers and anybody who's interested.

Quick Links

  • Home
  • About
  • Categories
  • Latest Research
  • Disclaimer

Contact

  • Contact Us
© 2025 Spinal Cord Research Help

All rights reserved.

  1. Home
  2. Research
  3. Spinal Cord Injury
  4. Human induced neural stem cells support functional recovery in spinal cord injury models

Human induced neural stem cells support functional recovery in spinal cord injury models

Experimental & Molecular Medicine, 2023 · DOI: https://doi.org/10.1038/s12276-023-01003-2 · Published: June 1, 2023

Spinal Cord InjuryRegenerative Medicine

Simple Explanation

Spinal cord injuries often lead to lasting sensory, motor, and autonomic disabilities. Currently, there's no standard medical treatment to reverse this damage. This study explores using induced neural stem cells (iNSCs) made from human urine cells to help spinal cord injury recovery in rats. The findings suggest that iNSCs could be a valuable tool for disease modeling and a potential source of personalized cells for nerve regeneration in spinal cord disorders.

Study Duration
8 weeks
Participants
Sprague–Dawley (SD) rats and nude rats (Crl:NIH-Foxn1rnu)
Evidence Level
Not specified

Key Findings

  • 1
    iNSCs derived from human urine cells can survive, engraft, and differentiate into neurons and glial cells when transplanted into injured spinal cords of rats.
  • 2
    Transplanted iNSCs led to the extension of axons over long distances, creating connections between the host and graft neurons.
  • 3
    Significant improvements in locomotor function were observed in the rat models of spinal cord injury after iNSC transplantation.

Research Summary

This study investigates the therapeutic potential of human urine-derived induced neural stem cells (iNSCs) in rat models of spinal cord injury (SCI). The researchers successfully generated iNSCs from human urine cells, fibroblasts, and patient-derived fibroblasts, demonstrating their ability to differentiate into various neuronal and glial cell types. Transplantation of these iNSCs into injured spinal cords resulted in cell survival, engraftment, axon extension, and improved locomotor function, suggesting a promising alternative for personalized cell-based therapies for SCI.

Practical Implications

Personalized Cell Therapy

iNSCs derived from patient urine cells can be used for autologous transplantation, reducing the risk of immune rejection.

Disease Modeling

iNSCs provide a valuable tool for studying the mechanisms of spinal cord injury and developing new therapeutic strategies.

Alternative Transplantation Strategy

iNSCs offer a safe and effective alternative to traditional stem cell sources, such as embryonic stem cells, for neural regeneration.

Study Limitations

  • 1
    Long-term effects of iNSC transplantation need further investigation.
  • 2
    Functional evaluations in large animal SCI models are needed.
  • 3
    Impact of iNSCs on other spinal cord diseases requires further study.

Your Feedback

Was this summary helpful?

Back to Spinal Cord Injury